Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF-mutated melanoma and other advanced malignancies
Minny Bhatty, Shumei Kato, Sarina A. Piha-Paul, Aung Naing, Vivek Subbiah, Helen J. Huang, Daniel D. Karp, Apostolia M. Tsimberidou, Ralph G. Zinner, Wen Jen Hwu, Milind Javle, Sapna P. Patel, Mimi I. Hu, Gauri R. Varadhachary, Anthony P. Conley, Nishma M. Ramzanali, Veronica R. Holley, Razelle Kurzrock, Funda Meric-Bernstam, Young Kwang ChaeKevin B. Kim, Gerald S. Falchook, Filip Janku*
Dive into the research topics of 'Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF-mutated melanoma and other advanced malignancies'. Together they form a unique fingerprint.